Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1009207 New York, NY
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,156,465
+135.3% QoQ
Ownership
0.725%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,165,536,060 across 26 Diagnostics & Research names. ADPT ranks #26 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 WAT
Waters Corp /De/
 948,639 $355,777,570
2 NTRA
Natera, Inc.
 1,279,255 $347,253,769
3 TMO
Thermo Fisher Scientific Inc.
 641,637 $321,691,125
4 ICLR
Icon PLC
 1,357,143 $235,749,309
5 A
Agilent Technologies, Inc.
 1,486,187 $197,410,218
6 GH
Guardant Health, Inc.
 1,255,658 $188,386,369
7 MEDP
Medpace Holdings, Inc.
 234,537 $124,208,448
8 IQV
Iqvia Holdings Inc.
 466,234 $90,085,733

All Filings in ADPT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 — 4,625,859
2026-03-31 — 1,965,610
2025-12-31 — 1,902,685
2025-09-30 — 738,176
2025-06-30 — 608,280
2023-12-31 — 41,743
2023-09-30 — 131,269
2023-06-30 — 87,948
2023-03-31 — 227,729
2022-12-31 — 116,182
2022-09-30 — 58,684
2022-06-30 — 156,184
2022-03-31 — 132,203
2020-06-30 — 19,068